Temozolomide is currently being used for aggressive brain tumors, among other cancers. The effectiveness of this treatment is reduced with tumor hypoxia (low oxygen levels). Hyperbaric oxygen therapy was shown in this study to reduce tumor hypoxia and thus help to increase the effectiveness of Temozolomide against the glioma, producing a much more powerful anti-tumor activity. This research is consistent with many recent studies showing the added effectiveness of hyperbaric oxygen therapy with conventional therapies like chemotherapy, in helping to increase the effectiveness of these therapies <view study> Read Less

“Idiopathic sudden sensorineural hearing loss (ISSHL) is the newest indication approved by the Undersea and Hyperbaric Medical Society’s Hyperbaric Oxygen Therapy Committee” Sound research combined with clinical efficacy has bolstered the use of hyperbaric oxygen therapy for this condition. It gives us new hope in the hyperbaric industry that more conditions can follow and get recognized for the many indications that have been shown in recent literature, combined with the results seen in many of the private hyperbaric centers throughout the world <view study> Read Less

Currently, hyperbaric oxygen therapy is a valuable hospital tool for diabetics with chronic non-healing wounds and is a therapy that is reserved for late stages of diabetics. With recent literature supporting the use of HBOT for earlier onset, this new study gives us further hope that hyperbaric oxygen should be used for early stage diabetes and not just reserved for later stages. Here, it was shown that obese, diabetic rats given HBOT enhanced glucose and lipid metabolism in the skeletal muscle. Since obesity runs rampant in the diabetic population, and the concomitant effects of blood sugar elevation damaging the small blood vessels of the body, HBOT may prove as a valuable resource for diabetics, not only for its aid in cardiovascular disease and wound healing support, but for also lowering the levels of blood sugar; thereby, causing less damage in the body <view study> Read Less

A new study has just been published in the journal of Diabetes (July 2012) illustrating the dramatic effects on mice when HBOT was applied. The study follows autoimmune diabetes development in non-obese diabetic mice. The results co-inside with other studies showing benefit for autoimmune diabetes. We now need to look at early intervention for children who are in the midst of developing Type 1 diabetes, and also for those that are at higher risk <view study> Read Less

Many private hyperbaric facilities are are providing HBOT for those inflicted with IBD, most commonly Crohn’s disease and Ulcerative Colitis. This new study demonstrates the usefulness of hyperbaric oxygen therapy for these conditions by showing the lowering of inflammatory markers and oxidative stress, alongside the improved clinical outcomes <view study> Read Less